AI Summary
This article discusses how CD4+ T cells with convergent TCR recombination can reprogram stroma and halt tumor progression in adoptive therapy. The study highlights the potential of these T cells to alter the tumor microenvironment and improve the effectiveness of immunotherapy treatments. This research has significant implications for the development of novel cancer therapies targeting the immune system.